Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial

Bernadett Szabados , Alejo Rodriguez-Vida , Ignacio Durán , Simon Crabb , Michiel van Der Heijden , Albert Font Pous , Gwenaelle Gravis (1, 2, 3) , Urbano Anido Herranz , Andrew Protheroe , Alain Ravaud , Denis Maillet , Maria Mendez-Vidal , Cristina Suárez , Mark Linch , Aaron Prendergast , Charlotte Tyson , Kelly Mousa , Daniel Castellano , Thomas Powles

1 IPC - Institut Paoli-Calmettes
2 Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, France.
3 CRCM - Centre de Recherche en Cancérologie de Marseille

Domaines: Cancer

Bernadett Szabados, Alejo Rodriguez-Vida, Ignacio Durán, Simon Crabb, Michiel van Der Heijden, et al.. Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial. European Urology Oncology, 2021, 4 (3), pp.456-463. ⟨10.1016/j.euo.2020.11.010⟩. ⟨hal-03623603⟩